Sign Up for a Free Account
  • Updated 02.26.2024
  • Released 03.28.1995
  • Expires For CME 02.26.2027

Basal ganglia hemorrhage



Basal ganglia hemorrhage is one of the most severe strokes. This update highlights important clinical trial results on the treatment of intracerebral hemorrhage, including blood pressure management and surgery.

Key points

• Intracerebral hemorrhage is an emergency requiring immediate evaluation and treatment.

• The most common cause of basal ganglia is hypertension.

• The risk of hematoma expansion and neurologic deterioration is highest within the first few hours from onset.

• Outcome depends on volume, location, age, level of consciousness, intraventricular extension, and warfarin use.

• Coagulopathy, if present, should be corrected.

• Rapid blood pressure control is safe but does not improve the clinical outcome.

• Surgical treatment has a limited role in the treatment of intracerebral hemorrhage.

• New endoscopic, minimally invasive surgical techniques are being tested with encouraging results.

Historical note and terminology

Intracerebral hemorrhage was described for the first time in 1658 by Wepfer in his treatise on apoplexy (59). He described both intracerebral hemorrhage and subarachnoid hemorrhage. Through the years, intracerebral hemorrhage has also been termed "cerebral hemorrhage," "intracranial hemorrhage," “hemorrhagic stroke,” and "cerebral bleed." The advent of head CT and brain MRI have greatly improved the detection, localization, and characterization of brain hemorrhages. Intracranial hemorrhage refers to any bleeding within the cranial vault, including subdural and epidural hematomas and subarachnoid hemorrhage. Intracerebral hemorrhage refers specifically to bleeding within the brain parenchyma. The term “hemorrhagic stroke” is best avoided as it is vague.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125